We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Adherence to Clinical Treatment of Glaucoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03338088
Recruitment Status : Active, not recruiting
First Posted : November 9, 2017
Last Update Posted : November 21, 2017
Sponsor:
Information provided by (Responsible Party):

November 7, 2017
November 9, 2017
November 21, 2017
September 1, 2017
November 6, 2017   (Final data collection date for primary outcome measure)
Evaluation of adherence to clinical treatment of glaucoma in patients of a Reference Ophthalmological Hospital in Goiânia [ Time Frame: 2 months ]
evaluation of the scale
Same as current
Complete list of historical versions of study NCT03338088 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Evaluation of Adherence to Clinical Treatment of Glaucoma
Evaluation of Adherence to Clinical Treatment of Glaucoma in Patients of a Reference Ophthalmological Hospital in Goiânia
Evaluation of adherence to clinical treatment of glaucoma in patients of a Reference Ophthalmological Hospital in Goiânia using Morisky Adhesion scale as a validated questionary.
Not Provided
Observational [Patient Registry]
Observational Model: Ecologic or Community
Time Perspective: Other
4 Months
Not Provided
Non-Probability Sample
All pacients that have glaucoma diagnosed that respond the questionary
Glaucoma; Drugs
Not Provided
Not Provided
Not Provided
 
Active, not recruiting
150
December 30, 2017
November 6, 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria: have glaucoma diagnosed -

Exclusion Criteria: not having glaucoma diagnosed

Sexes Eligible for Study: All
1 Year to 100 Years   (Child, Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Brazil
 
 
NCT03338088
INSTITUTO DE OLHOS-MAYRA 2018
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Plan to Share IPD: No
Instituto de Olhos de Goiania
Instituto de Olhos de Goiania
Not Provided
Study Director: Joao jr Nassaralla, coordinator coordinator
Instituto de Olhos de Goiania
November 2017